Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation

Journal of Experimental Medicine

Volumn 208, Issue 3, 2011, Pages 479-490

  Pedroza Gonzalez, Alexander ^a,i   Xu, Kangling ^a,b   Wu, Te Chia ^a,b,j   Aspord, Caroline ^a,k   Tindle, Sasha ^a   Marches, Florentina ^a   Gallegos, Michael ^a   Burton, Elizabeth C ^d   Savino, Daniel ^d   Hori, Toshiyuki ^e   Tanaka, Yuetsu ^f   Zurawski, Sandra ^a   Zurawski, Gerard ^a   Bover, Laura ^g   Liu, Yong Jun ^g   Banchereau, Jacques ^a,h,l   Palucka, A Karolina ^a,c,h  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b BAYLOR UNIVERSITY   (United States)

^c Integraal Kankercentrum Rotterdam   (Netherlands)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^e KYOTO UNIVERSITY   (Japan)

^f UNIVERSITY OF THE RYUKYUS   (Japan)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j RITSUMEIKAN UNIVERSITY   (Japan)

^k INSERM   (France)

^l HOFFMANN LA ROCHE INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; NEUTRALIZING ANTIBODY; OX40 LIGAND; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR;

ARTICLE; BREAST TUMOR; CANCER CELL; CANCER INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MASTITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; TH2 CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; CYTOKINES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; NEOPLASM TRANSPLANTATION; OX40 LIGAND; TH2 CELLS;

EID: 79952721606     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20102131     Document Type: Article

References (61)

1. Ali, S.A., M. Ahmad, J. Lynam, C.S. McLean, C. Entwisle, P. Loudon, E. Choolun, S.E. McArdle, G. Li, S. Mian, and R.C. Rees. 2004. Anti-tumour therapeutic efficacy of OX40L in murine tumour model. Vaccine. 22:3585-3594. doi:10.1016/j.vaccine.2004.03.041 (Pubitemid 39099634)
2. + T cells that facilitate tumor development. J. Exp. Med. 204:1037-1047. doi:10.1084/jem. 20061120
3. Bell, D., P. Chomarat, D. Broyles, G. Netto, G.M. Harb, S. Lebecque, J. Valladeau, J. Davoust, K.A. Palucka, and J. Banchereau. 1999. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med. 190:1417-1426. doi:10.1084/jem.190.10.1417
4. Berzofsky, J.A., and M. Terabe. 2008. A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity. Cancer Immunol. Immunother. 57:1679-1683. doi:10.1007/s00262-008-0495-4
5. Brimnes, M.K., L. Bonifaz, R.M. Steinman, and T.M. Moran. 2003. Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein. J. Exp. Med. 198:133-144. doi:10.1084/jem.20030266 (Pubitemid 36870193)
6. Camp, J.T., F. Elloumi, E. Roman-Perez, J. Rein, D.A. Stewart, J.C. Harrell, C.M. Perou, and M.A. Troester. 2011. Interactions with fibroblasts are distinct in Basal-like and luminal breast cancers. Mol. Cancer Res. 9:3-13. doi:10.1158/1541-7786.MCR-10-0372
7. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, I. Durand, M. Cella, A. Lanzavecchia, and J. Banchereau. 1997. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood. 90:1458-1470. (Pubitemid 27355417)
8. Condeelis, J., and J.W. Pollard. 2006. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 124:263-266. doi:10.1016/j.cell.2006.01.007 (Pubitemid 43121975)
9. Coughlin, S.S., and D.U. Ekwueme. 2009. Breast cancer as a global health concern. Cancer Epidemiol. 33:315-318. doi:10.1016/j.canep.2009.10.003
10. Coussens, L.M., and Z. Werb. 2002. Inflammation and cancer. Nature. 420:860-867. doi:10.1038/nature01322 (Pubitemid 36019639)
11. Croft, M., T. So, W. Duan, and P. Soroosh. 2009. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol. Rev. 229:173-191. doi:10.1111/j.1600-065X.2009.00766.x
12. DeNardo, D.G., J.B. Barreto, P. Andreu, L. Vasquez, D. Tawfik, N. Kolhatkar, and L.M. Coussens. 2009. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 16:91-102. doi:10.1016/j.ccr.2009.06.018
13. Dudziak, D., A.O. Kamphorst, G.F. Heidkamp, V.R. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H.W. Lee, C.G. Park, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science. 315:107-111. doi:10.1126/science.1136080 (Pubitemid 46196991)
14. Finkelman, F.D., A. Lees, R. Birnbaum, W.C. Gause, and S.C. Morris. 1996. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157:1406-1414. (Pubitemid 126449077)
15. Gilliet, M., V. Soumelis, N. Watanabe, S. Hanabuchi, S. Antonenko, R. de Waal-Malefyt, and Y.J. Liu. 2003. Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J. Exp. Med. 197:1059-1063. doi:10.1084/jem.20030240 (Pubitemid 36523204)
16. Gobert, M., I. Treilleux, N. Bendriss-Vermare, T. Bachelot, S. Goddard-Leon, V. Arfi, C. Biota, A.C. Doffin, I. Durand, D. Olive, et al. 2009. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 69:2000-2009. doi:10.1158/0008-5472.CAN-08-2360
17. Grivennikov, S.I., F.R. Greten, and M. Karin. 2010. Immunity, inflammation, and cancer. Cell. 140:883-899. doi:10.1016/j.cell.2010.01.025
18. Hackett, A.J., H.S. Smith, E.L. Springer, R.B. Owens, W.A. Nelson-Rees, J.L. Riggs, and M.B. Gardner. 1977. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J. Natl. Cancer Inst. 58:1795-1806.
19. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J.V. Ravetch, R.M. Steinman, and M.C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-779. doi:10.1084/jem.194.6.769 (Pubitemid 32983013)
20. Heibein, J.A., I.S. Goping, M. Barry, M.J. Pinkoski, G.C. Shore, D.R. Green, and R.C. Bleackley. 2000. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax. J. Exp. Med. 192:1391-1402. doi:10.1084/jem.192.10.1391
21. Iorio, M.V., M. Ferracin, C.G. Liu, A. Veronese, R. Spizzo, S. Sabbioni, E. Magri, M. Pedriali, M. Fabbri, M. Campiglio, et al. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65:7065-7070. doi:10.1158/0008-5472.CAN-05-1783 (Pubitemid 41161233)
22. Ito, T., Y.H. Wang, O. Duramad, T. Hori, G.J. Delespesse, N. Watanabe, F.X. Qin, Z. Yao, W. Cao, and Y.J. Liu. 2005. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 202:1213-1223. doi:10.1084/jem.20051135 (Pubitemid 41586952)
23. Kapp, U., W.C. Yeh, B. Patterson, A.J. Elia, D. Kägi, A. Ho, A. Hessel, M. Tipsword, A. Williams, C. Mirtsos, et al. 1999. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J. Exp. Med. 189:1939-1946. doi:10.1084/jem.189.12.1939
24. Khaled, W.T., E.K. Read, S.E. Nicholson, F.O. Baxter, A.J. Brennan, P.J. Came, N. Sprigg, A.N. McKenzie, and C.J. Watson. 2007. The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development. Development. 134:2739-2750. doi:10.1242/dev.003194 (Pubitemid 47307230)
25. Klechevsky, E., R. Morita, M. Liu, Y. Cao, S. Coquery, L. Thompson-Snipes, F. Briere, D. Chaussabel, G. Zurawski, A.K. Palucka, et al. 2008. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity. 29:497-510. doi:10.1016/j.immuni.2008.07.013
26. Lacroix, M., and G. Leclercq. 2004. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res. Treat. 83:249-289. doi:10.1023/B:BREA.0000014042.54925.cc (Pubitemid 38264873)
27. Levings, M.K., S. Gregori, E. Tresoldi, S. Cazzaniga, C. Bonini, and M.G. Roncarolo. 2005. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood. 105:1162-1169. doi:10.1182/blood-2004-03-1211 (Pubitemid 40170889)
28. Liu, Y.J., V. Soumelis, N. Watanabe, T. Ito, Y.H. Wang, Rde.W. Malefyt, M. Omori, B. Zhou, and S.F. Ziegler. 2007a. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu. Rev. Immunol. 25:193-219. doi:10.1146/annurev.immunol.25.022106.141718 (Pubitemid 46697907)
29. Luft, T., M. Jefford, P. Luetjens, T. Toy, H. Hochrein, K.A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky. 2002. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood. 100:1362-1372. doi:10.1182/blood-2001-12-0360 (Pubitemid 34864293)
30. Maldonado-López, R., T. De Smedt, P. Michel, J. Godfroid, B. Pajak, C. Heirman, K. Thielemans, O. Leo, J. Urbain, and M. Moser. 1999. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587-592. doi:10.1084/jem.189. 3.587 (Pubitemid 29187380)
31. Mantovani, A., and A. Sica. 2010. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22:231-237. doi:10.1016/j.coi.2010.01.009
32. Mantovani, A., P. Romero, A.K. Palucka, and F.M. Marincola. 2008. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet. 371:771-783. doi:10.1016/S0140-6736(08)60241-X
33. Morris, A., J.T. Vetto, T. Ramstad, C.J. Funatake, E. Choolun, C. Entwisle, and A.D. Weinberg. 2001. Induction of anti-mammary cancer immunity by engaging the OX-40 receptor in vivo. Breast Cancer Res. Treat. 67:71-80. doi:10.1023/A:1010649303056 (Pubitemid 32703390)
34. Neve, R.M., K. Chin, J. Fridlyand, J. Yeh, F.L. Baehner, T. Fevr, L. Clark, N. Bayani, J.P. Coppe, F. Tong, et al. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 10:515-527. doi:10.1016/j.ccr.2006.10.008 (Pubitemid 44854747)
35. Park, J.M., M. Terabe, L.T. van den Broeke, D.D. Donaldson, and J.A. Berzofsky. 2005. Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13. Int. J. Cancer. 114:80-87. doi:10.1002/ijc.20669 (Pubitemid 40194311)
36. Park, J.M., M. Terabe, D.D. Donaldson, G. Forni, and J.A. Berzofsky. 2008. Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation. Cancer Immunol. Immunother. 57:907-912. doi:10.1007/s00262-007-0414-0
37. Piconese, S., B. Valzasina, and M.P. Colombo. 2008. OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J. Exp. Med. 205:825-839. doi:10.1084/jem.20071341 (Pubitemid 351549881)
38. Pulendran, B., J.L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C.R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA. 96:1036-1041. doi:10.1073/pnas.96.3.1036
39. Rakoff-Nahoum, S., and R. Medzhitov. 2009. Toll-like receptors and cancer. Nat. Rev. Cancer. 9:57-63. doi:10.1038/nrc2541
40. Sarin, A., M.S. Williams, M.A. Alexander-Miller, J.A. Berzofsky, C.M. Zacharchuk, and P.A. Henkart. 1997. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity. 6:209-215. doi:10.1016/S1074-7613(00)80427-6 (Pubitemid 27145565)
41. Shimamura, T., T. Fujisawa, S.R. Husain, B. Joshi, and R.K. Puri. 2010. Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy. Clin. Cancer Res. 16:577-586. doi:10.1158/1078- 0432.CCR-09-2015
42. Skinnider, B.F., A.J. Elia, R.D. Gascoyne, L.H. Trümper, F. von Bonin, U. Kapp, B. Patterson, B.E. Snow, and T.W. Mak. 2001. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 97:250-255. doi:10.1182/blood.V97.1.250 (Pubitemid 32061267)
43. Skinnider, B.F., A.J. Elia, R.D. Gascoyne, B. Patterson, L. Trumper, U. Kapp, and T.W. Mak. 2002. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 99:618-626. doi:10.1182/blood.V99.2.618 (Pubitemid 34533100)
44. Smirnov, D.A., and V.G. Cheung. 2008. ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs. Am. J. Hum. Genet. 83:243-253. doi:10.1016/j.ajhg.2008.07.003
45. Soule, H.D., J. Vazguez, A. Long, S. Albert, and M. Brennan. 1973. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51:1409-1416.
46. Soumelis, V., P.A. Reche, H. Kanzler, W. Yuan, G. Edward, B. Homey, M. Gilliet, S. Ho, S. Antonenko, A. Lauerma, et al. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3:673-680. (Pubitemid 34752477)
47. Steinbrink, K., H. Jonuleit, G. Müller, G. Schuler, J. Knop, and A.H. Enk. 1999. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood. 93:1634-1642. (Pubitemid 29102491)
48. Steinman, R.M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature. 449:419-426. doi:10.1038/nature06175 (Pubitemid 47509552)
49. Steinman, R.M., D. Hawiger, and M.C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711. doi:10.1146/annurev.immunol.21. 120601.141040 (Pubitemid 37174545)
50. Swift, M., P.J. Reitnauer, D. Morrell, and C.L. Chase. 1987. Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med. 316:1289-1294. doi:10.1056/NEJM198705213162101 (Pubitemid 17084026)
51. Terabe, M., S. Matsui, N. Noben-Trauth, H. Chen, C. Watson, D.D. Donaldson, D.P. Carbone, W.E. Paul, and J.A. Berzofsky. 2000. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1:515-520. doi:10.1038/82771
52. Terabe, M., S. Matsui, J.M. Park, M. Mamura, N. Noben-Trauth, D.D. Donaldson, W. Chen, S.M. Wahl, S. Ledbetter, B. Pratt, et al. 2003. Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J. Exp. Med. 198:1741-1752. doi:10.1084/jem.20022227 (Pubitemid 37494166)
53. Todaro, M., Y. Lombardo, M.G. Francipane, M.P. Alea, P. Cammareri, F. Iovino, A.B. Di Stefano, C. Di Bernardo, A. Agrusa, G. Condorelli, et al. 2008. Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ. 15:762-772. doi:10.1038/sj.cdd.4402305 (Pubitemid 351405081)
54. Trieu, Y., X.Y. Wen, B.F. Skinnider, M.R. Bray, Z. Li, J.O. Claudio, E. Masih-Khan, Y.X. Zhu, S. Trudel, J.A. McCart, et al. 2004. Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo. Cancer Res. 64:3271-3275. doi:10.1158/0008-5472.CAN-03-3764 (Pubitemid 38581432)
55. Villablanca, E.J., L. Raccosta, D. Zhou, R. Fontana, D. Maggioni, A. Negro, F. Sanvito, M. Ponzoni, B. Valentinis, M. Bregni, et al. 2010. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat. Med. 16:98-105. doi:10.1038/nm.2074
56. Watanabe, N., S. Hanabuchi, M.A. Marloie-Provost, S. Antonenko, Y.J. Liu, and V. Soumelis. 2005a. Human TSLP promotes CD40 ligand-induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential. Blood. 105:4749-4751. doi:10.1182/blood-2004-09-3622 (Pubitemid 40807299)
57. Watanabe, N., Y.H. Wang, H.K. Lee, T. Ito, Y.H. Wang, W. Cao, and Y.J. Liu. 2005b. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 436:1181-1185. doi: 10.1038/nature03886 (Pubitemid 41232298)
58. Weinberg, A.D., M.M. Rivera, R. Prell, A. Morris, T. Ramstad, J.T. Vetto, W.J. Urba, G. Alvord, C. Bunce, and J. Shields. 2000. Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J. Immunol. 164:2160-2169. (Pubitemid 30108775)
59. Xie, F., Q. Wang, Y. Chen, Y. Gu, H. Mao, W. Zeng, and X. Zhang. 2010. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Pathol. Res. Pract. 206:735-739. doi:10.1016/j.prp.2010.05.016
60. Zhang, W.J., B.H. Li, X.Z. Yang, P.D. Li, Q. Yuan, X.H. Liu, S.B. Xu, Y. Zhang, J. Yuan, G.S. Gerhard, et al. 2008. IL-4-induced Stat6 activities affect apoptosis and gene expression in breast cancer cells. Cytokine. 42:39-47. doi:10.1016/j.cyto.2008.01.016
61. Ziegler, S.F., and D. Artis. 2010. Sensing the outside world: TSLP regulates barrier immunity. Nat. Immunol. 11:289-293. doi:10.1038/ni.1852